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PCLINICAL RESEARCH Coronary Artery Disease
Coronary Artery Calcium to Predict
All-Cause Mortality in Elderly Men and Women
Paolo Raggi, MD,*† Maria C. Gongora, MD,* Ambarish Gopal, MD,‡ Tracy Q. Callister, MD,§
Matthew Budoff, MD,‡ Leslee J. Shaw, PHD*
Atlanta, Georgia; Torrance, California; and Nashville, Tennessee
Objectives We sought to study the prognostic utility of coronary artery calcium (CAC) in the elderly.
Background The prognostic significance of CAC in the elderly is not well known.
Methods All-cause mortality was assessed in 35,388 patients (3,570 were 70 years old at screening, and 50% were
women) after a mean follow-up of 5.8  3 years.
Results In older patients, risk factors and CAC were more prevalent. Overall survival was 97.9% at the end of follow-up.
Mortality increased with each age decile with a relative hazard of 1.09 (95% confidence interval: 1.08 to 1.10,
p  0.0001), and rates were greater for men than women (hazard ratio: 1.53; 95% confidence interval: 1.32 to
1.77, p  0.0001). Increasing CAC scores were associated with decreasing survival across all age deciles (p 
0.0001). Survival for a 40-year and 80-year-old man with a CAC score 400 was 88% and 19% (95% and
44% for a woman, p  0.0001), respectively. Among the 20,562 patients with no CAC, annual mortality rates
ranged from 0.3% to 2.2% for patients age 40 to 49 years or 70 years (p  0.0001). The use of CAC allowed
us to reclassify more than 40% of the patients 70 years old more often by excluding risk (i.e., CAC 400) in
those with 3 risk factors.
Conclusions Despite their limited life expectancy, the use of CAC discriminates mortality risk in the elderly. Furthermore, the
use of CAC allows physicians to reclassify risk in the elderly. (J Am Coll Cardiol 2008;52:17–23) © 2008 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.04.004v
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doronary artery calcium (CAC) is currently recognized as
n independent and incremental predictor of events in
atients at intermediate risk of coronary artery disease, and
everal guidelines support selective screening in these pa-
ients (1–3). Preliminary evidence has also been found in
igh-risk subjects such as diabetic patients (4) and smokers
5), where CAC seems to add prognostic significance to risk
actors. Whether CAC screening has prognostic value when
ssessing risk in older patients has not been extensively
esearched.
The currently used risk estimation tools are heavily
nfluenced by age as a surrogate marker of atherosclerosis
urden. Although atherosclerosis progresses with advancing
ge, there is a substantial heterogeneity among adult indi-
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ents from General Electric, Amersham, and Astellas Pharmaceuticals.s
Manuscript received January 31, 2008; revised manuscript received March 18,
008, accepted April 2, 2008.iduals of the same age. If plaque burden were an accurate
stimate of risk in older subjects, it could be substituted for
ge in risk calculations as suggested by Grundy (6). In this
rospective observational study, we estimated rates of all-
ause death in 35,383 patients referred by primary care
hysicians for CAC screening. Among these, 3,570 were
lder than 70 years at the time of screening. We estimated
he risk of death in 6 age deciles (40 to 80 years) and in
arious CAC score categories (from 10 to 1,000) for
oth men and women.
ethods
tudy cohort and data collection. We included 35,388
symptomatic patients referred by primary care physicians
or CAC screening with electron beam tomography (EBT)
n 2 U.S. cities (Nashville, Tennessee, and Torrance, Cali-
ornia). Patients with known or suspected coronary artery
isease were excluded. At CAC screening, all subjects
rovided informed consent to the use of their blinded data
or research purposes, and further authorization was ob-
ained from the institutional internal review boards. A
etailed questionnaire was collected at the time of EBT
canning with the help of a nurse or a research coordinator.
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Coronary Calcium in the Elderly July 1, 2008:17–23Risk factors were recorded as
categorical variables in all patients.
Diabetes was defined as treatment
with hypoglycemic agents or insu-
lin, fasting glucose126 mg/dl or
known but untreated hyperglyce-
mia. Hypertension was defined as
blood pressure 140/90 mm Hg
or treatment with antihypertensive
agents. A history of smoking was
considered present if patients cur-
rently smoked or smoked until 6
onths before the study. Hypercholesterolemia was defined as
reatment with lipid-lowering drugs, known dyslipidemia not
reated with medications, or fasting total cholesterol 200
g/dl. A positive family history included a first-degree relative
ho had a major cardiovascular event before age 55 years in
en or 65 years in women.
BT imaging. We performed EBT scans with a C-150
canner (Imatron, San Francisco, California). About 40
ontiguous, 3-mm thick tomographic slices were obtained
etween the carina and the diaphragm. Exposure time was
00 ms/slice, and the total radiation dose was 0.6 mSv. The
AC score was calculated according to the Agatston
ethod (7).
ortality ascertainment. Patients were followed for a mean
f 5.8  3 years (median 5.0 years, interquartile range: 3.8 to
.8 years) after CAC screening. The occurrence of all-cause
eath was verified via the National Death Index. Follow-up
as completed in 100% of patients. In total 838 deaths were
ecorded, 320 in women and 518 in men.
tatistical methods. Categorical variables were compared
ith the chi-square test. The mean (standard deviation)
umber of risk factors was compared across age deciles with the
nalysis of variance techniques. Univariable and multivariable
ox proportional hazards survival models were calculated,
linical Characteristics of the Study Cohort (N  35,383)
Table 1 Clinical Characteristics of the Study Cohort (N  35,3
<40 40–49
n 2,571 9,319
Women 50% 52%
Family history of coronary artery disease 42% 41%
Smoking 15% 16%
Diabetes mellitus 2% 3%
Hypertension 24% 30%
Hyperlipidemia 22% 28%
Number of risk factors 0.9  1 1.0  1
Percent with 3 risk factors 11% 15%
Prevalence of calcium score
10 90% 76%
11–100 8% 16%
101–400 1.4% 6%
01–1,000 0.4% 2%
1,000 0.2% 0.4%
Abbreviations
and Acronyms
CAC  coronary artery
calcium
CI  confidence interval
EBT  electron beam
tomography
FRS  Framingham risk
score
HR  hazard rationcluding hazard ratios (HRs) and 95% confidence intervals
CIs) for time to all-cause mortality. From the multivariable
odels, risk-adjusted survival rates were calculated. We calcu-
ated annual mortality rates by dividing the predicted mortality
y total follow-up time (in years). Separate Cox models for
AC scores were devised for each age decile. Within each age
ecile multivariable model, a gender by CAC first-order test
or interaction was calculated. Finally, a comparison of risk
eclassification was performed with a categorical comparison of
he Framingham risk score (FRS) groups by CAC scores
400 and 400 with the chi-square test. The percentage of
atients reclassified included the low-intermediate FRS pa-
ients with a CAC score400 and the percentage of high FRS
atients with a CAC score 400. The cost to identify 1 new
igh risk case or death was calculated at an EBT cost of U.S.
100.
Figure 1 Unadjusted Survival by Gender
Age (yrs)
0–59 60–69 70–79 >80 p Value
2,478 7,449 3,122 448
51% 47% 46% 47% 0.0001
41% 38% 38% 34% 0.0001
16% 14% 12% 5% 0.0001
5% 7% 10% 10% 0.0001
36% 42% 46% 46% 0.0001
32% 34% 35% 31% 0.0001
.1  1 1.3  1 1.6  1 1.6  1 0.0001
17% 21% 31% 29% 0.0001
0.0001
58% 40% 25% 16%
22% 24% 21% 16%
13% 20% 25% 24%
5% 10% 16% 18%
2% 6% 13% 27%83)
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July 1, 2008:17–23 Coronary Calcium in the Elderlyesults
linical characteristics of study patients. The patients’
haracteristics are shown in Table 1; at screening, 3,570
atients were 70 years old. Older patients had a greater
isk factor burden, except for smoking. The average number
f risk factors was 1.6 for patients age 70 years and 0.9 for
hose age 40 years (p  0.0001).
umulative survival and survival according to calcium
core. Overall survival was 97.9% but varied by gender
98.2% for women; 97.1% for men, p  0.0001) (Fig. 1).
he relative hazard was increased for older patients and
en. Overall mortality increased with each age decile (HR:
.09, 95% CI: 1.08 to 1.10, p  0.0001) (Fig. 2).
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Follow-up (in yrs):
Median                       4.6  4.7         4.9     4.9        4.8       
25th %ile                    3.7           3.7         3.7      3.7        3.8       
75th %ile                     6.5            6.5        6.4          6.6        6.3       
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Figure 2 Gender-Specific Mortality Rates
Unadjusted all-cause mortality rates by gender and age deciles at 4 to 6 years of
Figure 3 Gender-Specific Survival According to Calcium Score
Risk-adjusted survival by coronary artery calcium across age deciles in women andortality rates were greater for men than women (HR:
.53, 95% CI: 1.32 to 1.77, p  0.0001).
Cumulative survival for CAC subsets varied by age
Fig. 3). In men, CAC scores from 0 to 10 were associated
ith risk-adjusted survival rates from 99.7% to 96.8% for
hose age 40 to 80 years (p  0.0001). For women,
he corresponding rates were 99.8% and 98.1%, respec-
ively (p  0.0001). Cumulative unadjusted survival of
40- and 80-year-old men with a calcium score 400
as 88% and 19%, respectively. By comparison, the
urvival of 40- and 80-year-old women with a cal-
ium score 400 was 95% and 44%, respectively
p  0.0001).
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Coronary Calcium in the Elderly July 1, 2008:17–23For men with CAC scores 1,000, risk-adjusted survival
anged from 98.8% to 74.9% for those 40 to 80 years
p  0.0001). Corresponding survival rates for women
anged from 98.6% to 85.8% (p  0.0001).
Table 2 details the risk-adjusted HRs by CAC score
ubsets compared with CAC scores from 0 to 10, in separate
ultivariable models within each age decile. For patients
40 years old with CAC scores 400, the relative hazards
ere 13-fold greater than with scores from 0 to 10 (p 
.0001). The HRs for CAC scores 400 were also in-
Risk-Adjusted Hazard Ratios (95% Confidence Infor Death According to CAC Scores Within S pa
Table 2 Risk-Adjusted Hazard Ratios (95% Cfor Death According to CAC Scores
CAC 11 to 100
Age 40 yrs 0.71 (0.09–5.47) p 0.75 11.20
Age 40–49 yrs 2.81 (1.40–5.67) p 0.004 5.91
Age 50–59 yrs 2.60 (1.68–4.02) p 0.0001 2.67
Age 60–69 yrs 2.58 (1.65–4.04) p 0.0001 3.95
Age 70–79 yrs 2.94 (1.64–5.27) p 0.0001 3.92
Age 80 yrs 6.26 (1.39–28.30) p 0.017 5.32
Hazard ratios compared with coronary artery calcium (CAC) scores fro
isk-Adjusted Hazard Ratios (95% Confidencentervals) From n Inter ction of Gender by CACco e in Ag Decile Subset
Table 3
Risk-Adjusted Hazard Ratios (95% Confidence
Intervals) From an Interaction of Gender by CAC
Score in Age Decile Subsets
Hazard Ratio 95% Confidence Interval p Value
Age 40 yrs
CAC score 0.0001
11–100 1.94 0.26–14.78 0.52
101–399 11.60 2.61–51.47 0.001
400 44.00 5.22–370.92 0.001
Age 40–49 yrs
CAC score 0.0001
11–100 2.56 1.13–5.81 0.025
101–399 8.86 3.89–20.22 0.0001
400 22.19 9.55–51.54 0.0001
Age 50–59 yrs
CAC score 0.0001
11–100 2.10 1.31–3.35 0.002
101–399 2.04 1.19–3.49 0.01
400 6.58 4.24–10.21 0.0001
Age 60–69 yrs
CAC score 0.0001
11–100 1.93 1.30–2.86 0.001
101–399 3.00 2.11–4.25 0.0001
400 5.10 3.68–7.06 0.0001
Age 70–79 yrs
CAC score 0.0001
11–100 1.52 0.96–2.40 0.075
101–399 1.69 1.12–2.54 0.012
400 3.04 2.20–4.21 0.0001
Age 80 yrs
CAC score 0.0001
11–100 1.71 0.70–4.16 0.24
101–399 1.03 0.45–2.38 0.94
400 3.21 1.94–5.32 0.0001AC  coronary artery calcium.reased in older patients compared with CAC scores of 0 to
0, although merely 2-fold.
Table 3 shows the risk factor-adjusted HRs from an
nteraction of age by gender. For patients age 40 years,
Rs were elevated from 2- to 44-fold for men versus
omen (p  0.0001) in low to high calcium scores. Hazard
atios difference between men and women were attenuated
ith increasing age.
For the 20,562 patients without CAC, annual mortality
ates ranged from 0.3% for those ages 40 to 49 years to 2.2%
or those 70 years (p  0.0001) (Fig. 4). The resulting
Rs were elevated 4.13-fold (95% CI: 1.71 to 9.97, p 
.0001) for those age 70 years (p  0.0001).
eclassification of risk. Figure 5 shows the proportion of
atients that could be reclassified based on a CAC score
400. The proportion ranged from 14.1% to 43.1% among
omen and 9.0% to 45.2% among men (p  0.0001). The
ajority of patients reclassified had CAC400 with a high
RS. Among women and men with 3 risk factors, 66.6%
nd 75% had CAC scores 400, respectively. Among
omen with 0 to 2 risk factors, 2.7% age 40 years were
eclassified as opposed to 61.5% and 30.5% of those age 70
o 79 and 80 years. For men, the respective proportions
ere 4.3%, 43.9%, and 28.8% (p  0.0001 for both
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Figure 4 Risk of Death Without CAC
Annual mortality (left y-axis) in patients without CAC by age decile including
hazard ratios (95% CIs; right y-axis) compared with patients 40 years. The
hazard ratios are shown next to the bar graphs. CAC  coronary artery
calcium; CI  confidence interval.
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July 1, 2008:17–23 Coronary Calcium in the Elderlyenders). Finally, Table 4 demonstrates the cost to identify
ne new high-risk case (CAC 400) and 1 death among
ow-intermediate risk patients. The cost decreases for older
ge groups compared with younger ones.
iscussion
he use of CAC is considered to be an age-dependent
henomenon, and most studies on CAC screening have not
ncluded the elderly. Our data show that the use of CAC
as prognostic utility even in the elderly, and those patients
ithout CAC have a good outcome compared with high
AC. Several elderly patients had no CAC and 56% with
3 risk factors had CAC 400; hence, they could be
0.0%
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6
Figure 5 Reclassification of Risk With the Use of Coronary Cal
Percentage of patients reclassified based on coronary artery calcium (CAC) 400
With a high FRS, patients were reclassified if CAC 400. With a low-intermediate
indicate the number of deaths identified beyond those defined by the FRS in each
Cost Analysis to Identify 1 New High-Risk Caseand 1 Death Among Low-Intermed ate Risk Pati
Table 4 Cost Analysis to Identify 1 New Higand 1 Death Among Low-Intermedia
Age Decile, yrs
Cost to Identify 1 New High
Patient With CAC >400
Women M
30–39 $22,260 (0.4%) $23,28
40–49 $6,354 (1.6%) $6,77
50–59 $1,736 (5.8%) $1,66
60–69 $743 (13.5%) $75
70–79 $405 (24.7%) $41
80 $247 (40.5%) $24For the left 2 columns, the percentage in parentheses indicates the proportion
For the right 2 columns, the percentage in parentheses indicates the death reclassified to a lower risk status. For younger patients, the
elative risk ratios revealed a wide gradient between those
ith and without CAC, likely because of the fact that
aseline risk and comorbidities affect risk in different ways
n the young and the elderly. Young patients without CAC
re at very low risk. However, among these patients,
igh-risk CAC scores occur in subjects with considerable
omorbidity, perhaps as the result of referral bias, with a
esultant greater relative risk of death. Conversely, most of
ur elderly patients had some degree of comorbidity and risk
actor burden, thus increasing their mortality risk.
It is currently challenging to identify asymptomatic el-
erly subjects at greater risk. The FRS (8) and European
CORE (Systemic COronary Risk Evaluation) (9) have an
6% 25.8% 33.9% 43.1%
8% 27.6% 37.2% 45.2%
-59 60-69 70-79 ≥80
6.0%               58.9% 49.0%                  27.8%
.9%               55.1%    56.2%                  30.8%
4.0%               41.1%                51.0%            72.2%
.1%               44.9%     3.8%                   69.2%
23
19
9
25
46
38
28
Scoring
00 (p  0.0001 for women and men) beyond the Framingham risk score (FRS).
atients were reclassified if CAC 400. The numbers at the top of each column
t subset.
k Case
sk Patients
Cost to Identify 1 Death in a High-Risk
Patient With CAC >400
Women Men
) $111,300 (0.1%) $116,400 (0.1%)
) $133,433 (0.1%) $65,483 (0.2%)
) $57,856 (0.2%) $20,872 (0.5%)
%) $12,022 (0.8%) $6,702 (1.5%)
%) $5,332 (1.9%) $2,995 (3.3%)
%) $1,700 (5.9%) $593 (16.9%)19.
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Coronary Calcium in the Elderly July 1, 2008:17–23pper age limit, and the predictive power of traditional risk
actors diminishes with advancing age (10,11). Further-
ore, the uniform weight attributed to age in risk algo-
ithms does not take into consideration the heterogeneity of
dult populations, which may induce risk miscalculation and
ead to inaccurate therapeutic elections. The use of athero-
clerosis imaging may help improve risk assessment in the
lderly.
Grundy (6) suggested that age be corrected for the burden
f atherosclerosis found on noninvasive imaging. Similarly,
iscussants at the Prevention-V Conference suggested the
ntegration of CAC scoring with traditional risk factors to
mprove global risk prediction (12). However, the current
vidence on CAC scoring in the elderly is limited. Vlieg-
nthart et al. (13) recruited 1,795 asymptomatic patients,
ith a mean age of 71 years, and recorded 88 cardiovascular
vents during a mean follow-up period of 3.3 years. They
eported a graded and statistically significant risk of events
ith increasing CAC scores in individuals 69 years or
70 years. The risk of cardiovascular events was very low in
atients with CAC  0 to 100 and increased 8.2-fold (95%
I: 3.3 to 20.5) in patients with CAC 1,000.
Abbott et al. (14) reported on 224 very old (ages 84 to 96
ears) Japanese men living in Hawaii. A total of 17 deaths
ccurred during 2.5 years of follow-up but none in patients
ith a CAC 10. As in the previous study (13), the death
ate increased significantly as the CAC score increased (p
.001). Newman et al. (15) followed 559 patients (336
omen) ages 70 to 99 years for 5 years. They reported that
oth CAC and carotid intima-media thickness are accurate
redictors of cardiovascular events and death. The top
uartile of each measurement was associated with 2-fold
ncreased risk of events. Limitations of these previous
tudies included a small total number of events, enrollment
f very elderly men (14), and the lack of a comparison of risk
etween young and older people (14,15).
On the contrary, we followed a large number of patients
f all ages (n  3,560 70 years, 50% women), and
ecorded numerous deaths. Because risk factors lose predic-
ion power with advancing age, and the absence of CAC
atches a low risk, it may be appropriate to mitigate
revention efforts in elderly patients with no evidence of
ubclinical atherosclerosis. In Western nations, the elderly
re the most rapidly growing segment of the population,
mposing increasing cost of care; hence, the need to focus
esources on truly necessary interventions exists.
tudy limitations. There were a few limitations to this
tudy: we collected only categorical risk factors, and ob-
ained information on vital status alone; the latter may have
educed the predictive ability of CAC for cardiovascular
vents. Nonetheless, all-cause death is not affected by
erification bias as other end points are (16), and most
eaths in adults are primarily linked to cardiovascular
iseases.onclusions
e conclude that the use of CAC scoring is an effective
isk stratification tool in the elderly as well as young
atients, rendering CAC of potential utility even in
igh-risk patients such as those with diabetes (17), those
ith renal failure (18), those who smoke (5) and, now,
he elderly. The use CAC screening in the elderly may
llow the implementation of new risk scoring methods as
roposed by Grundy (6), where the burden of atheroscle-
osis is substituted for age (19). It may not be ethical to
esign studies to assess whether the absence of CAC
llows withholding preventive therapies in elderly pa-
ients with risk factors. However, the low risk associated
ith the absence of CAC, and the relative cost utility of
he method, could encourage some physicians to mitigate
he intensity of primary prevention in the elderly even in
he absence of strong prospective evidence.
eprint requests and correspondence: Dr. Paolo Raggi, 1365
lifton Road NE, AT-504, Atlanta, Georgia 30322. E-mail:
raggi@emory.edu.
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